Global Acid Protease Powder Market Strategic Research Report
By Type: Fungal Acid Protease Powder, Microbial Recombinant Acid Protease Powder, Animal-Derived Acid Protease Powder
By Application: Food, Feed, Leather, Other
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Kerry Group plc (ISE: KRZ, Tralee Ireland), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Nagase & Co., Ltd. (TYO: 8012, Tokyo Japan), Biocatalysts Ltd. (Unlisted, Wales UK), Creative Enzymes (Unlisted, New York USA), SunHY(Unlisted, Hubei China), Hunan Hongying Biological Technology Co., Ltd. (Unlisted, Hunan China), Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China), Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China), Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China), Sunsonzyme (Unlisted, Beijing China)
نظرة عامة
Scope of the Report
The global Acid Protease Powder market size is predicted to grow from US$ 98 million in 2025 to US$ 149 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Acid protease powder is a solid enzyme preparation produced through microbial fermentation, extraction, purification, and drying (e.g., spray drying, freeze drying). Its core characteristic is maintaining high catalytic activity in an acidic pH environment, enabling efficient hydrolysis of protein peptide bonds. Demand primarily stems from the food industry (e.g., cheese curd, meat tenderizer, baking improver), the feed industry (as a premix additive to improve protein digestibility), and the leather and textile industry (depilatory softening powder), which require enzyme preparations with specific requirements for stability in dry form, long shelf life, low transportation costs, and ease of dry mixing. The upstream supply chain involves strain development (high-yield acidic protease strains), fermentation raw material supply (soybean meal, corn steep liquor, etc.), and the manufacturing of fermentation and spray drying equipment. Downstream, it directly connects with food processing plants, feed production companies, tanneries, and scientific reagent distributors, ultimately being applied in various solid or low-moisture processing systems. In 2025, the production of acid protease powder is estimated at approximately 10,000 tons, with an average price of approximately US$10,000 per ton, a gross profit margin of approximately 30%, and a single-line capacity of 150 tons per year.
Global key Acid Protease Powder players cover Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), etc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Acid Protease Powder market?
What factors are driving Acid Protease Powder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acid Protease Powder market opportunities vary by end market size?
How does Acid Protease Powder break out by Type, by Application?
This report presents a comprehensive overview of the global Acid Protease Powder market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Fungal Acid Protease Powder
- Microbial Recombinant Acid Protease Powder
- Animal-Derived Acid Protease Powder
Segment by Product Form
- Carrier-Bound Type
- Microencapsulated
- Lyophilized Trpe
Segment by Application
- Food
- Feed
- Leather
- Other
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Acid Protease Powder market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Food, Feed, Leather evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Acid Protease Powder Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Fungal Acid Protease Powder
- 3.1.3 Microbial Recombinant Acid Protease Powder
- 3.1.4 Animal-Derived Acid Protease Powder
- 3.1.5 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Food
- 4.1.3 Feed
- 4.1.4 Leather
- 4.1.5 Other
- 4.1.6 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Novonesis (CPH: NZYM B, Bagsværd Denmark)
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 International Flavors & Fragrances Inc. (NYSE: IFF, New York USA)
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland)
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Amano Enzyme Inc. (TYO: 2802, Aichi Japan)
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China)
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 AB Enzymes GmbH (Unlisted, Darmstadt Germany)
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Kerry Group plc (ISE: KRZ, Tralee Ireland)
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India)
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 Nagase & Co., Ltd. (TYO: 8012, Tokyo Japan)
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Biocatalysts Ltd. (Unlisted, Wales UK)
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Creative Enzymes (Unlisted, New York USA)
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 SunHY(Unlisted, Hubei China)
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Hunan Hongying Biological Technology Co., Ltd. (Unlisted, Hunan China)
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China)
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China)
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China)
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Sunsonzyme (Unlisted, Beijing China)
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Acid Protease Powder market size?
What growth rate is expected for the Acid Protease Powder market through 2032?
How is Acid Protease Powder defined?
What are the main segments of the Acid Protease Powder market by type?
Which applications drive demand in the Acid Protease Powder market?
Who are the key players in the Acid Protease Powder market?
Which regions and countries are covered for Acid Protease Powder?
What is driving growth in the Acid Protease Powder market?
Who should buy the Acid Protease Powder market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Acid Protease Powder Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Chemicals & Advanced Materials